Gene Modified Allogeneic Neuroblastoma Cells

· St. Jude Children's Research Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene Modified Allogeneic Neuroblastoma Cells, covering 2008-06-03 to 2008-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma [Phase 1]